Unlocking New Therapeutic Strategies in Oligometastatic Prostate Cancer with Radioligand and Metastasis-directed Radiation Therapy

In metastatic prostate cancer, the disease may spread to only a few sites in some cases, which is called oligometastatic prostate cancer (omPC). We describe a combined treatment strategy for patients with omPC. Radiotherapy targets tumors in specific areas, while radioligand therapy (which involves injection of a radioactive drug) can reach cancer cells throughout the body. Combining these two treatments may improve cancer control for both the primary tumor and metastases.